Figure 2From: Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of LifeVariations (mean ± SD) in QoL in TMZ/WBRT treated pts. Statistical analysis has been performed by ANOVA comparing different time pts to the baseline values.Back to article page